Woman and Man
- | Country :
- Canada
- Australia
- Ukraine
- The 6 others...
- | organs : -
- | Specialty : -
Extract
This was an 18-month, multi-center, open-label, clinical extension study. Patients completing earlier second extension studies (CACZ885H2356E2 and CACZ885H2357E2) continued to be treated in this combined extension 3 study for any new gouty arthritis flare on demand with one subcutaneous (s.c.) injection of canakinumab 150 mg.
Inclusion criteria
- Acute Gouty Arthritis Flares